Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gynecology
  3. A short chain fatty acid from the intestinal microbiota to fight endometriosis?
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gynecology
  3. A short chain fatty acid from the intestinal microbiota to fight endometriosis?
Gynecology

A short chain fatty acid from the intestinal microbiota to fight endometriosis?

Endometriosis
Gynecology General Medicine

Endometriosis considerably changes the quality of life of women suffering from the pain and infertility it causes. Although it affects 1 in 10 women, its mechanisms are poorly understood and treatments for it are unsatisfactory. A recent study1 in animals opens new perspectives by showing that butyrate, a short-chain fatty acid produced by the intestinal microbiota, slows the development of endometriotic lesions.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

About this article

Created 14 December 2021
Updated 31 August 2023

The theories about the origin of endometriosis have not yet been clarified. According to the hypothesis which is prevalent today, fragments of the endometrium migrate out of the uterus into the peritoneal cavity during retrograde menstruation and implant themselves into the surrounding tissues. However, although 90% of women have retrograde menstruation only 10% have endometriosis. In addition, the current treatments for the disease have side effects and do not prevent relapses. 

In order to offer women new treatment solutions, other factors contributing to the alteration of the peritoneal environment and the development of lesions must be identified. In this context the intestinal microbiota has aroused the attention of researchers. In fact, the intestinal microbiota of women suffering from endometriosis presents a lower alpha diversity and a changed bacterial composition compared to women without endometriosis. In addition, the metabolites produced by the colonic flora of a mouse model for endometriosis are different to those of the control mice. This is important because it is through the metabolites from the transformation of dietary fibres that the intestinal microbiota provides its benefit to the human body. Amongst these, the short-chain fatty acids (SCFA), such as butyrate, acetate or propionate, in particular have anti-proliferation and anti-inflammatory effects. The authors of the study published in Life Science Alliance therefore considered the role of these SCFAs in endometriosis in vivo on a mouse model for endometriosis and in vitro on cells of endometriotic lesions.

Butyrate inhibits the growth of lesions by activating several mechanisms

The initial results show that endometriosis upsets the balance of the intestinal microbiota of mice by causing a reduction in the production of butyrate. The team also observed that butyrate (and not other SCFAs such as acetate or propionate) inhibits the growth of endometriotic lesions. Butyrate acts through at least three mechanisms: by activating membrane receptors coupled to G-proteins (GPCRs): GPR43 and GPR109A, by inhibiting the enzyme histone deacetylase (HDAC) and activating Rap1GAP (protein activating GTPase Ras-proximate-1). Rap1GAP blocks the Rap1 signal pathway involved in the proliferation, migration and adhesion of cells. It is already known to be a tumour suppressor, including in endometrial cancer.

New studies must now determine whether, in women suffering from endometriosis, the faecal butyrate level is lower than in women who do not suffer. If this is the case, different approaches intended to prevent the development of lesions could be tested: diet, butyrate analogues, butyrate-based supplements or probiotics inducing the production of butyrate.

Recommended by our community

"Thanks for this article!!" - Comment translated from Diome🌺 (From Biocodex Microbiota Institute on X)

Sources

1 Chadchan, Sangappa B et al. “Gut microbiota-derived short-chain fatty acids protect against the progression of endometriosis.” Life science alliance 2021 Sep 30;4(12):e202101224.

Tags
Endometriosis Butyrate Short-chain fatty acid

en_view en_sources

    Created 14 December 2021
    Updated 31 August 2023

    About this article

    To know more about this topic.

    Main topic

    Endometriosis

    Medical practice

    Gynecology General Medicine

    Content type

    News
    Gynecology

    From diarrhea to chronic diseases: the well-documented consequences of antibiotic-related gut microbiota dysbiosis

    Antibiotic treatment may sometimes take place without any...

    Find out more

    Vaginal Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Vaginal Microbiota # 16

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Vaginal microbiota # 14

    By Pr. Markku VoutilainenTurku University Faculty of Medicine; Turku University Hospital, Department of Gas...

    Find out more

    Vaginal Microbiota #15

    By Pr. Markku VoutilainenTurku University Faculty of Medicine; Turku University Hospital, Department of Gas...

    Find out more

    Urinary tract infections

    Infections of the lower urogenital tract are extremely common amongst women: seven out of ten women will su...

    Find out more

    Vaginal microbiota #10

    By Pr. Markku VoutilainenTurku University Faculty of Medicine; Turku University Hospital, Department of Gas...

    Find out more

    Targeting the gut microbiota to optimize vaccine efficacy?

    by Dr Genelle Healey

    Find out more

    Continue reading

    News
    27.11.2023

    Predicting the risk of preterm birth through vaginal microbiota

    Read the article
    Actu PRO : Une antibiothérapie prophylactique péri-partum appauvrit le lait maternel en Bifidobacterium
    12.03.2019

    Peripartum prophylactic antibiotic therapy decreases bifidobacterium levels in breast milk

    Read the article
    28.10.2021

    6 things you should know about antibiotics

    Read the article
    28.10.2021

    Antimicrobial resistance: a global threat, an international response

    Read the article
    05.10.2023

    Fusobacterium to blame for endometriosis?

    Read the article
    25.10.2022

    Antibiotics: Dr Jekyll and Mr Hyde

    Read the article
    25.09.2023

    Recurrent miscarriage: a case study on vaginal microbiota transplantation (VMT)

    Read the article
    02.03.2021

    Cervicovaginal microbiota: a marker for persistent papillomavirus infection?

    Read the article
    What's worth reading about microbiota
    Follow us on X
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    Microbiota 17 EN
    Check out our latest magazine
    The first 1000 days of life
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    27.11.2023

    Predicting the risk of preterm birth through vaginal microbiota

    Read the article

    Antimicrobial resistance: Doctor, your role is essential! Patient, your behavior is key!

    In November, Biocodex and the Biocodex Microbiota Institu...

    Find out more
    22.11.2023

    Is vaginal microbiota transfer the new miracle for C-section babies?

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo